Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-191426
Filing Date
2007-08-29
Accepted
2007-08-29 11:40:33
Documents
8
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 809536
2 SUMMARY OF COMPENSATION ARRANGEMENTS dex1025.htm EX-10.25 6861
3 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 2693
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (KPMG LLP) dex231.htm EX-23.1 2678
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (ERNST & YOUNG LLP) dex232.htm EX-23.2 5745
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9253
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9227
8 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 4429
  Complete submission text file 0001193125-07-191426.txt   851786
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-26642 | Film No.: 071086004
SIC: 2835 In Vitro & In Vivo Diagnostic Substances